|
|
Post by mnkdnewbie on Nov 14, 2016 10:07:54 GMT -5
Anyone notice anything?
|
|
|
|
Post by peppy on Nov 14, 2016 10:10:23 GMT -5
heh
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Nov 14, 2016 10:10:41 GMT -5
today is world diabetes day and they are honoring Frederick Banting for his insulin discovery.
and this is not thread worthy.
title is irrelevant and could be better to convey whats the thread about. <fail>
|
|
|
|
Post by mnkdnewbie on Nov 14, 2016 10:16:57 GMT -5
Does that make you feel better?
|
|
|
|
Post by lakon on Nov 15, 2016 11:28:26 GMT -5
When does Al Mann and his team at MNKD get credit for creating the first thermostable active monomeric human insulin? After 90 years of Banting, surely it is worth noting by someone as smart as Google...
|
|
|
|
Post by rockstarrick on Nov 15, 2016 14:45:41 GMT -5
When does Al Mann and his team at MNKD get credit for creating the first thermostable active monomeric human insulin? After 90 years of Banting, surely it is worth noting by someone as smart as Google... Hard to believe something like Afrezza can fly beneath the radar for so long !! whether it's lack of advertising, lack of interest in a new INHALED mealtime insulin that seems to work better than all other mealtime insulin products, or a complete mutiny by BP, the FDA, and our Healthcare system, it is still mind boggling to me. The three most mind boggling things in America today 1) Donald Trump beats Hillary Clinton for POTUS 2) The Chicago Cubs win the World Series 3) Afrezza is still unknown to the majority of Dr's and PWD The first two give me hope that Afrezza can still win !! |
|
|
|
Post by sportsrancho on Nov 15, 2016 15:20:18 GMT -5
|
|
|
|
Post by lakon on Nov 16, 2016 9:57:14 GMT -5
When does Al Mann and his team at MNKD get credit for creating the first thermostable active monomeric human insulin? After 90 years of Banting, surely it is worth noting by someone as smart as Google... Hard to believe something like Afrezza can fly beneath the radar for so long !! whether it's lack of advertising, lack of interest in a new INHALED mealtime insulin that seems to work better than all other mealtime insulin products, or a complete mutiny by BP, the FDA, and our Healthcare system, it is still mind boggling to me. The three most mind boggling things in America today 1) Donald Trump beats Hillary Clinton for POTUS 2) The Chicago Cubs win the World Series 3) Afrezza is still unknown to the majority of Dr's and PWD The first two give me hope that Afrezza can still win !! Sounds like a Trifecta to me! Wait for it @sportsrancho: TV ads are coming! |
|
|
|
Post by mnholdem on Nov 16, 2016 11:13:33 GMT -5
Endos will need convincing publications in the NEJM or AMA before they'll get on board with Afrezza, and many still won't be convinced about Afrezza's real-world results until safety data trials. Perhaps even some of the PCPs and 3rd party payers will want this empirical evidence from a reputable source.
Many shareholders have been saying it for two years: Afrezza demand will prove to be patient-driven. MannKind needs to implement DTC marketing in order to gain traction and then sustain robust sales growth. The majority of PWD probably don't even use social media. Unless they are told about Afrezza, they won't even know it exists as a treatment option. If their endo/PCP won't tell them about Afrezza, then TV advertising is the only way to reach this population.
 |
|
|
|
Post by saxcmann on Nov 16, 2016 11:27:56 GMT -5
Endos will need convincing publications in the NEJM or AMA before they'll get on board with Afrezza, and many still won't be convinced about Afrezza's real-world results until safety data trials. Perhaps even some of the PCPs and 3rd party payers will want this empirical evidence from a reputable source.
Many shareholders have been saying it for two years: Afrezza demand will prove to be patient-driven. MannKind needs to implement DTC marketing in order to gain traction and then sustain robust sales growth. The majority of PWD probably don't even use social media. Unless they are told about Afrezza, they won't even know it exists as a treatment option. If their endo/PCP won't tell them about Afrezza, then TV advertising is the only way to reach this population.
You nailed it mnholdem! This is exactly what's needed! 10 thumbs up! |
|
